Mar 15
CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP
Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market
Mar 15
Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market
Jan 18
Commanding shareholder approval better positions management to attain enterprise business objectives going forward.
Jan 04
Agenda includes transformational matters affecting the Company’s position to manage impending growth
Nov 30
Agenda to include matters necessary to better position the company for anticipated growth and development.